Leerink Partners analyst Mani Foroohar reiterated a Buy rating on Abeona Therapeutics (ABEO – Research Report) on February 16 and
Tag: NASDAQ:ABEO
Abeona Therapeutics (ABEO) Gets a Buy Rating from H.C. Wainwright
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Abeona Therapeutics (ABEO – Research
B.Riley Financial Thinks Abeona Therapeutics’ Stock is Going to Recover
In a report released today, Justin Zelin from B.Riley Financial reiterated a Buy rating on Abeona Therapeutics (ABEO – Research
Analysts Offer Insights on Healthcare Companies: Abeona Therapeutics (NASDAQ: ABEO) and Incyte (NASDAQ: INCY)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abeona Therapeutics (ABEO – Research
B.Riley FBR Initiates a Buy Rating on Abeona Therapeutics (ABEO)
In a report issued on September 17, Justin Zelin from B.Riley FBR initiated coverage with a Buy rating on Abeona
Mizuho Securities Maintains Their Hold Rating on Abeona Therapeutics (ABEO)
In a report issued on September 12, Difei Yang from Mizuho Securities maintained a Hold rating on Abeona Therapeutics (ABEO
Abeona Therapeutics (ABEO) Receives a Buy from H.C. Wainwright
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Abeona Therapeutics (ABEO – Research